COMMUNIQUÉS West-GlobeNewswire

Nephros Launches the Nephros Water Institute to Lead National Water Safety Education
11/12/2025
New initiative accelerates cross-industry engagement, expands educational reach to drive long-term growth in water quality solutions SOUTH ORANGE, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a [...]
Williamsburg Therapy Group Joins the Lumina Therapy Alliance, Strengthening the Nation’s Premier Network of High-End In-Person Mental Health Practices
11/12/2025
NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Lumina Therapy Alliance , the country’s first and only curated collective of elite, out-of-network in-person mental health practices, is proud to announce that Williamsburg [...]
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
11/12/2025
LA JOLLA, CA, Dec. 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the [...]
NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review
11/12/2025
GAINESVILLE, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- NeXtGen Biologics is pleased to report that the USPTO declined to initiate Inter Partes Review (“IPR”), following the filing by RegenX Science of two IPR Petitions in [...]
Acentra Health Names Patty Obermaier as Chief Growth Officer
11/12/2025
Proven healthcare leader to drive growth and product innovation in support of the company’s mission to accelerate better health outcomes MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
11/12/2025
No Stockholder Action Required at this Time DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today [...]
Eclipse Energy Announces Collaborative Partnership with Weatherford Accelerating Commercialization of Subsurface Clean Energy Technologies
11/12/2025
HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Eclipse Energy today announced a collaborative partnership with Weatherford International plc (NASDAQ: WFRD) that includes a capital investment from Weatherford to accelerate [...]
Graham and Courtney Rahal Foundation Donates $225,000 to SoldierStrong Through Vino for Vets Event
11/12/2025
NAPA VALLEY, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Graham & Courtney Rahal Foundation (GCRF) hosted its fourth-annual Vino For Vets powered by DropLight fundraiser in October, donating $225,000 to benefit [...]
Parsley Health Launches BYO Labs Review: The First Clinician-Led Service Turning Outside Lab Data Into Personalized Health Plans
11/12/2025
New York, New York, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Parsley Health , the nationally recognized functional medicine platform known for combining advanced diagnostics with root-cause medical care, today announced the [...]
MD Logic Health & Well Minerals Launch Pure Whole Food Vitamin C, a Premium, 100% Natural Vitamin C Supplement Sourced Exclusively from Organic Fruit
11/12/2025
Miami, FL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In an era where consumers are increasingly conscious of the origins and quality of their nutritional supplements, Well Minerals x MD Logic Health® 's new collaboration [...]
Certara Appoints Jon Resnick as Chief Executive Officer
11/12/2025
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year [...]
InnoCare Announces Approval of the Next-Generation TRK Inhibitor Zurletrectinib in China
11/12/2025
BEIJING, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its next-generation TRK inhibitor, zurletrectinib (ICP-723), has received [...]
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
11/12/2025
NEW YORK and AMSTERDAM, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by [...]
Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
11/12/2025
Study did not meet the primary or key secondary endpoint 45% reduction in hypoglycemia events observed at top ersodetug dose (10 mg/kg) compared to 40% improvement in placebo arm Management to host conference call today [...]
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025
11/12/2025
In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically meaningful improvements in OS, PFS, and ORR, reinforcing Plinabulin as a late- [...]
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Atopic Dermatitis
11/12/2025
Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial KT-621 BROADEN2 Phase 2b AD trial ongoing, with data expected to be reported by mid-2027 and [...]
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications
11/12/2025
Mario Alberto Accardi PhD, President and founder of Centessa’s Orexin Program, appointed Chief Executive Officer and member of the Board of Directors BOSTON and LONDON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Centessa [...]
Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss
11/12/2025
CRB-913 was safe and well-tolerated across all doses studied Daily neuropsychiatric assessments using CSSRS, PHQ-9, and GAD-7 were negative for all participants A placebo-adjusted mean weight loss of 2.9% was observed [...]
Redecan Cannabis Brand Elevates the Diamond Vape Category with the Launch of Amped Live Resin Liquid Diamond Vapes
11/12/2025
TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness [...]

Pages